Allied Market Research
Loading...
0
New
New
2021
Biotech Ingredients Market

Biotech Ingredients Market by Type (Active Pharmaceutical Ingredients and Biosimilars), Product (Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, and Blood Factors), and Expression Systems (Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, and Insect Expression Systems): Global Opportunity Analysis and Industry Forecast, 2021–2028

A11345
Pages: 300
May 2021 | 2845 Views
   
Author(s) : Yamini Parihar , Eswara Prasad
Tables: 129
Charts: 79
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Biotech Ingredients Market

Request Now !

Biotech Ingredients Market Outlook - 2021–2028

The global biotech ingredient market size was valued at $51.3 billion in 2020, and is anticipated to generate $75.3 billion by 2028. The market is projected to experience growth at a CAGR of 4.8% from 2021 to 2028.

Biotech ingredients are chemical compounds that are similar to compounds found in nature. These ingredients have similar structure to that of natural ones and are produced through several complex processes. Genetic engineering, recombinant DNA technology, hybridoma technology, and gene transfer are some technologies that are used to produce these compounds. These ingredients are experiencing rapid growth from personal care, aromatic, and herbal products, which drives growth of the biotech ingredients market.

Biotech-Ingredients-Market

Get more information on this report : Request Sample Pages

There is a notable shift in demand from synthetic ingredients to biotech ingredients. This is attributed to rise in awareness in consumers regarding harmful effects of synthetic products. In-addition, rise in use of generic medicines has also led to rise in demand for organic or herbal generics, i.e., generics made from biotech ingredients, which propels the market growth. Moreover, growth in use of biotech ingredients in the food and beverages industry also significantly acts as growth driver for the biotech ingredients market growth. However, limited availability of raw material acts as restraint for the biotech ingredients market growth

The biotech ingredient market is segmented on the basis of type, product, application, and region. Depending on type, the market is bifurcated into active pharmaceutical ingredients (API) and Biosimilars. By product, it is categorized into monoclonal antibodies, vaccines, hormones & growth factors, cytokines, fusion proteins, therapeutic enzymes, and blood factors. By expression systems, it is divided into mammalian expression systems, microbial expression systems, yeast expression systems, plant expression systems, and insect expression systems. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA (Latin America, Middle East, and Africa).

The key players operating in the market are Pfizer Inc., Novartis International AG, Merck & Co., Teva Pharmaceutical Industries Ltd., Mylan, Inc., Boehringer Ingelheim, Sanofi, AbbVie, Eli Lilly and Company, and  AstraZeneca plc. The players in the market have adopted several strategies, such as product launch and business expansion, to sustain the market competition.  

Biotech Ingredients Market, by Type

On the basis of type, the APIs segment garnered highest biotech ingredients market share in 2020, owing to increase in use of generic medicines in the wake of pandemic, especially herbal immunity boosters. The APIs segment garnered the highest market share for year 2020 owing to increased use of generic medicines in the wake of pandemic especially herbal immunity boosters. However, biosimilars are expected to dominate the market during the forecast period. This is owed to the fact that they are used abundantly as both finished as well as raw material for many generics as well as patent medicines and other products. 

Biotech Ingredients Market
By Type

Your browser does not support the canvas element.

Biosimilars is projected as the most lucrative segment.

Get more information on this report : Request Sample Pages

Biotech Ingredients Market, by Product

Depending on product, the monoclonal antibodies segment dominated the biotech ingredients market share for 2020, owing to growing demand for organic and herbal medicines for various diseases. However, hormones & growth factors segment is projected to grow at higher CAGR during the forecast period. this can be attributed to owing to increasing health and hormonal problems that arise from current lifestyles.

Biotech Ingredients Market
By Product

Your browser does not support the canvas element.

Hormones and Growth Factors Ingredients are projected as the most lucrative segment.

Get more information on this report : Request Sample Pages

Biotech Ingredients Market, by Expression Systems

On the basis of expression systems, the microbial expression systems segment dominated the market share in 2020 owing to low cost of production and simple procedure. However, mammalian expression systems segment is expected to grow at faster pace during the forecast period owing to use in production of antibodies and therapeutic proteins. 

Biotech Ingredients Market
By Expression Systems

Your browser does not support the canvas element.

Mammalian Expression Systems are projected as the most lucrative segment.

Get more information on this report : Request Sample Pages

Biotech Ingredients Market, by Region

By region, the biotech ingredient market analysis is done across North America, Europe, Asia-Pacific, and LAMEA. Europe region dominated the market in 2020 on account of large consumer base, end-use sectors, and favorable support from government. Asia-Pacific is expected to grow fastest forecast period owing to presence of large bio-pharmaceutical companies in the countries such as China, India, Japan, and South Korea. In-addition the region also has a rich history of using herbal medicines that also adds to its rich expertise in the biotech ingredients. 

Biotech Ingredients Market
By Region

2028
Europe 
North America
Asia-pacific
Lamea

Asia-Pacific is projected as the most lucrative market.

Get more information on this report : Request Sample Pages

COVID-19 Impact Analysis

The outbreak of COVID-19 pandemic had led to partial or complete shutdown of production facilities, which do not come under essential goods, owing to prolonged lockdown in major countries such as the U.S., China, Japan, India, and Germany. It has led to either closure or suspension of their production activities in most industrial units across the globe. Furthermore, the global economy was deeply impacted by implementation of lockdown, as many activities came to halt. The biotech ingredients market saw a decline in its growth as the pandemic progressed. This can be attributed to the fact that research and development activities were halted as funds were being directed for sustaining economic unrest by many players. Moreover, supply demand chain for raw materials was disrupted that only added to already scarce availability pertaining in the market. 

Key Benefits For Stakeholders

  • The report provides an in-depth analysis and biotech ingredients market forecast along with the current and future market trends.
  • This report highlights the key drivers, opportunities, and restraints of the biotech ingredients market along with the impact analyses during the forecast period.
  • Porter’s five forces analysis helps analyze the potential of the buyers & suppliers and the competitive scenario of the biotech ingredients industry for strategy building.
  • A comprehensive analysis of the factors that drive and restrain the market growth is provided.
  • The qualitative data in this report aims on biotech ingredients market trends, dynamics, and developments.
  • The biotech ingredients market size is provided in terms of revenue.

Key Market Segments

By Type

  • Active Pharmaceutical Ingredients
  • Biosimilars

By Product

  • Monoclonal Antibodies 
  • Vaccines 
  • Hormones and Growth Factors 
  • Cytokines
  • Fusion Proteins
  • Therapeutic Enzymes
  • Blood Factors

By Expression Systems

  • Mammalian Expression Systems
  • Microbial Expression Systems
  • Yeast Expression Systems
  • Plant Expression Systems
  • Insect Expression Systems

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific 
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific 
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA 

Key Players

  • Pfizer Inc.
  • Novartis International AG
  • Merck & Co.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan, Inc.
  • Boehringer Ingelheim
  • Sanofi
  • AbbVie
  • Eli Lilly and Company
  • AstraZeneca plc
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Value chain analysis
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Shift in consumer preference from synthetic to bio-based ingredients
3.5.1.2.Development in biotechnology

3.5.2.Restraint

3.5.2.1.Limited availability of raw material

3.5.3.Opportunity

3.5.3.1.Favorable government policies and technological advancements in bio-engineering

3.6.Patent analysis
3.7.Impact of COVID-19 on the biotech ingredients market

CHAPTER 4:BIOTECH INGREDIENTS MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Active pharmaceutical ingredients

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region

4.3.Biosimilars

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region

CHAPTER 5:BIOTECH INGREDIENTS MARKET, BY PRODUCT

5.1.Overview

5.1.1.Market size and forecast

5.2.Monoclonal antibodies

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region

5.3.Vaccines

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region

5.4.Hormones & growth factors

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region

5.5.Cytokines

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region

5.6.Fusion proteins

5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast, by region

5.7.Therapeutic enzymes

5.7.1.Key market trends, growth factors, and opportunities
5.7.2.Market size and forecast, by region

5.8.Blood factors

5.8.1.Key market trends, growth factors, and opportunities
5.8.2.Market size and forecast, by region

CHAPTER 6:BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS

6.1.Overview

6.1.1.Market size and forecast

6.2.Mammalian expression systems

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region

6.3.Microbial expression systems

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region

6.4.Yeast Expression Systems

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region

6.5.Plant Expression Systems

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by region

6.6.Insect expression systems

6.6.1.Key market trends, growth factors, and opportunities
6.6.2.Market size and forecast, by region

CHAPTER 7:BIOTECH INGREDIENTS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by type
7.2.3.Market size and forecast, by product
7.2.4.Market size and forecast, by expression systems
7.2.5.Market size and forecast, by country
7.2.6.U.S.

7.2.6.1.Market size and forecast, by type
7.2.6.2.Market size and forecast, by product
7.2.6.3.Market size and forecast, by expression systems

7.2.7.Canada

7.2.7.1.Market size and forecast, by type
7.2.7.2.Market size and forecast, by product
7.2.7.3.Market size and forecast, by expression systems

7.2.8.Mexico

7.2.8.1.Market size and forecast, by type
7.2.8.2.Market size and forecast, by product
7.2.8.3.Market size and forecast, by expression systems

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by type
7.3.3.Market size and forecast, by product
7.3.4.Market size and forecast, by expression systems
7.3.5.Market share analysis, by country
7.3.6.Germany

7.3.6.1.Market size and forecast, by type
7.3.6.2.Market size and forecast, by product
7.3.6.3.Market size and forecast, by expression systems

7.3.7.UK

7.3.7.1.Market size and forecast, by type
7.3.7.2.Market size and forecast, by product
7.3.7.3.Market size and forecast, by expression systems

7.3.8.France

7.3.8.1.Market size and forecast, by type
7.3.8.2.Market size and forecast, by product
7.3.8.3.Market size and forecast, by expression systems

7.3.9.Italy

7.3.9.1.Market size and forecast, by type
7.3.9.2.Market size and forecast, by product
7.3.9.3.Market size and forecast, by expression systems

7.3.10.Spain

7.3.10.1.Market size and forecast, by type
7.3.10.2. Market size and forecast, by product
7.3.10.3. Market size and forecast, by expression systems

7.3.11.Rest of Europe

7.3.11.1. Market size and forecast, by type
7.3.11.2. Market size and forecast, by product
7.3.11.3.Market size and forecast, by expression systems

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by type
7.4.3.Market size and forecast, by product
7.4.4.Market size and forecast, by expression systems
7.4.5.Market share analysis, by country
7.4.6.China

7.4.6.1.Market size and forecast, by type
7.4.6.2.Market size and forecast, by product
7.4.6.3.Market size and forecast, by expression systems

7.4.7.Japan

7.4.7.1.Market size and forecast, by type
7.4.7.2.Market size and forecast, by product
7.4.7.3.Market size and forecast, by expression systems

7.4.8.India

7.4.8.1.Market size and forecast, by type
7.4.8.2.Market size and forecast, by product
7.4.8.3.Market size and forecast, by expression systems

7.4.9.South Korea

7.4.9.1.Market size and forecast, by type
7.4.9.2.Market size and forecast, by product
7.4.9.3.Market size and forecast, by expression systems

7.4.10.Australia

7.4.10.1.Market size and forecast, by type
7.4.10.2.Market size and forecast, by product
7.4.10.3.Market size and forecast, by expression systems

7.4.11.Rest of Asia-Pacific

7.4.11.1.Market size and forecast, by type
7.4.11.2.Market size and forecast, by product
7.4.11.3.Market size and forecast, by expression systems

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by type
7.5.3.Market size and forecast, by product
7.5.4.Market size and forecast, by expression systems
7.5.5.Market share analysis, by country
7.5.6.Brazil

7.5.6.1.Market size and forecast, by type
7.5.6.2.Market size and forecast, by product
7.5.6.3.Market size and forecast, by expression systems

7.5.7.Saudi Arabia

7.5.7.1.Market size and forecast, by type
7.5.7.2.Market size and forecast, by product
7.5.7.3.Market size and forecast, by expression systems

7.5.8.South Africa

7.5.8.1.Market size and forecast, by type
7.5.8.2.Market size and forecast, by product
7.5.8.3.Market size and forecast, by expression systems

7.5.9.Rest of LAMEA

7.5.9.1.Market size and forecast, by type
7.5.9.2.Market size and forecast, by product
7.5.9.3.Market size and forecast, by expression systems

CHAPTER 8:COMPETITIVE LANDSCAPE

8.1.Introduction

8.1.1.Market player positioning, 2020

8.2.Top winning strategies

8.2.1.Top winning strategies, by year
8.2.2.Top winning strategies, by development
8.2.3.Top winning strategies, by company

8.3.Key developments

8.3.1.Acquisitions
8.3.2.New Product launches

CHAPTER 9:COMPANY PROFILES

9.1.AstraZeneca plc

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating Segments
9.1.4.Product portfolio
9.1.5.Business performance

9.2.Merck & Co.

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating Segments
9.2.4.Product portfolio
9.2.5.Business performance

9.3.Abbvie

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Product portfolio
9.3.4.Business performance
9.3.5.Key Developmental strategies

9.4.MYLAN N.V.

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Type portfolio
9.4.4.Business performance
9.4.5.Key Developmental strategies

9.5.NOVARTIS INTERNATIONAL AG

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Type portfolio
9.5.5.Business performance

9.6.PFIZER INC.

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Type portfolio
9.6.5.Business performance

9.7.SANOFI S.A.

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Type portfolio
9.7.5.Business performance

9.8.Boehringer Ingelheim

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Product portfolio

9.9.TEVA PHARMACEUTICAL INDUSTRIES LTD.

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Type portfolio
9.9.4.Business performance

9.10.ELI LILLY AND COMPANY

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Product portfolio
9.10.4.Business performance

LIST OF TABLES

TABLE 01.GLOBAL BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 02.ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 03.BIOSIMILARS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 04.GLOBAL BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 05.MONOCLONAL ANTIBODIES BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 06.VACCINES BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 07.HORMONES & GROWTH FACTORS BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 08.CYTOKINES BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 09.FUSION PROTEINS BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 10.THERAPEUTIC ENZYMES BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 11.BLOOD FACTORS BIOTECH INGREDIENTS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 12.GLOBAL BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 13.BIOTECH INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2020–2028 ($MILLION)
TABLE 14.BIOTECH INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY REGION, 2020–2028 ($MILLION)
TABLE 15.BIOTECH INGREDIENTS MARKET, FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2028 ($MILLION)
TABLE 16.BIOTECH INGREDIENTS MARKET FOR PLANT EXPRESSION SYSTEMS, BY REGION, 2020–2028 ($MILLION)
TABLE 17.BIOTECH INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY REGION, 2020–2028 ($MILLION)
TABLE 18.BIOTECH INGREDIENTS MARKET, BY REGION, 2020--2028 ($MILLION)
TABLE 19.NORTH AMERICA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 20.NORTH AMERICA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 21.NORTH AMERICA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 22.NORTH AMERICA BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 23.U.S. BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 24.U.S. BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 25.U.S. BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 26.CANADA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 27.CANADA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 28.CANADA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 29.MEXICO BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 30.MEXICO BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 31.MEXICO BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 32.EUROPE BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 33.EUROPE BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 34.EUROPE BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 35.EUROPE BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 36.GERMANY BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 37.GERMANY BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 38.GERMANY BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 39.UK BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 40.UK BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 41.UK BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 42.FRANCE BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 43.FRANCE BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 44.FRANCE BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 45.ITALY BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 46.ITALY BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 47.ITALY BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 48.SPAIN BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 49.SPAIN BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 50.SPAIN BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 51.REST OF EUROPE BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 52.REST OF EUROPE BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 53.REST OF EUROPE BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 54.ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 55.ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 56.ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 57.ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 58.CHINA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 59.CHINA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 60.CHINA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 61.JAPAN BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 62.JAPAN BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 63.JAPAN BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 64.INDIA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 65.INDIA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 66.INDIA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 67.SOUTH KOREA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 68.SOUTH KOREA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 69.SOUTH KOREA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 70.AUSTRALIA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 71.AUSTRALIA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 72.AUSTRALIA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 74.REST OF ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 75.REST OF ASIA-PACIFIC BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 76.LAMEA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 77.LAMEA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 78.LAMEA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 79.LAMEA BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 80.BRAZIL BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 81.BRAZIL BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 82.BRAZIL BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 83.SAUDI ARABIA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 84.SAUDI ARABIA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 85.SAUDI ARABIA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 86.SOUTH AFRICA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 87.SOUTH AFRICA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 88.SOUTH AFRICA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 89.REST OF LAMEA BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 90.REST OF LAMEA BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 91.REST OF LAMEA BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILLION)
TABLE 92.KEY ACQUISITION (2017-2021)
TABLE 93.NEW PRODUCT LAUNCHES (2017-2021)
TABLE 94.ASTRAZENECA: COMPANY SNAPSHOT
TABLE 95.ASTRAZENECA: OPERTAING SEGMENTS
TABLE 96.ZYDUS CADILA: PRODUCT PORTFOLIO
TABLE 97.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 98.MERCK & CO.: COMPANY SNAPSHOT
TABLE 99.MERCK & CO.: OPERTAING SEGMENTS
TABLE 100.MERCK & CO.: PRODUCT PORTFOLIO
TABLE 101.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 102.ABBVIE: COMPANY SNAPSHOT
TABLE 103.ABBVIE: PRODUCT PORTFOLIO
TABLE 104.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 105.ABBVIE: KEY DEVELOPMENTAL STRATEGIES
TABLE 106.MYLAN: COMPANY SNAPSHOT
TABLE 107.MYLAN: PRODUCT PORTFOLIO
TABLE 108.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 109.MYLAN: PRODUCT PORTFOLIO
TABLE 110.NOVARTIS: COMPANY SNAPSHOT
TABLE 111.NOVARTIS: OPERATING SEGMENTS
TABLE 112.NOVARTIS: PRODUCT PORTFOLIO
TABLE 113.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 114.PFIZER INC.: COMPANY SNAPSHOT
TABLE 115.PFIZER INC.: OPERATING SEGMENTS
TABLE 116.PFIZER INC.: PRODUCT PORTFOLIO
TABLE 117.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 118.SANOFI: COMPANY SNAPSHOT
TABLE 119.SANOFI: OPERATING SEGMENTS
TABLE 120.SANOFI: PRODUCT PORTFOLIO
TABLE 121.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 122.BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 123.BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 124.TEVA: COMPANY SNAPSHOT
TABLE 125.TEVA: PRODUCT PORTFOLIO
TABLE 126.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 127.ELI LILLY AND COMPANY: COMPANY SNAPSHOT
TABLE 128.ELI LILLY AND COMPANY: PRODUCT PORTFOLIO
TABLE 129.OVERALL FINANCIAL STATUS ($MILLION)

LIST OF FIGURES

FIGURE 01.KEY MARKET SEGMENTS
FIGURE 02.GLOBAL BIOTECH INGREDIENTS MARKET SNAPSHOT, BY SEGMENTATION, 2020–2028
FIGURE 03.BIOTECH INGREDIENTS MARKET SNAPSHOT, BY COUNTRY, 2020–2028
FIGURE 04.TOP INVESTMENT POCKETS
FIGURE 05.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06.HIGH THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE THREAT OF SUBSTITUTES
FIGURE 08.LOW INTENSITY OF RIVALRY
FIGURE 09.HIGH BARGAINING POWER OF BUYERS
FIGURE 10.VALUE CHAIN ANALYSIS FOR BIOTECH INGREDIENTS MARKET
FIGURE 11.BIOTECH INGREDIENTS MARKET DYNAMICS
FIGURE 12.BIOTECH INGREDIENTS PATENT ANALYSIS
FIGURE 13.GLOBAL BIOTECH INGREDIENTS MARKET, BY TYPE, 2020–2028 ($MILILION)
FIGURE 14.COMPARATIVE ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF PEM BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 16.GLOBAL BIOTECH INGREDIENTS MARKET, BY PRODUCT, 2020–2028 ($MILILION)
FIGURE 17.COMPARATIVE ANALYSIS OF MONOCLONAL ANTIBODIES BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF VACCINES BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF HORMONES & GROWTH FACTORS BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF CYTOKINES BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF FUSION PROTEINS BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF THERAPEUTIC ENZYMES BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF BLOOD FACTORS BIOTECH INGREDIENTS MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 24.GLOBAL BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEMS, 2020–2028 ($MILILION)
FIGURE 25.COMPARATIVE ANALYSIS OF BIOTECH INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 26.COMPARATIVE ANALYSIS OF BIOTECH INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 27.COMPARATIVE ANALYSIS OF BIOTECH INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 28.COMPARATIVE ANALYSIS OF BIOTECH INGREDIENTS MARKET FOR PLANT EXPRESSION SYSTEMS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 29.COMPARATIVE ANALYSIS OF BIOTECH INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 30.U.S. BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 31.CANADA BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 32.MEXICO BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 33.GERMANY BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 34.UK BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 35.FRANCE BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 36.ITALY BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 37.SPAIN BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 38.REST OF EUROPE BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 39.CHINA BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 40.JAPAN BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 41.INDIA BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 42.SOUTH KOREA BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 43.AUSTRALIA BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 44.REST OF ASIA-PACIFIC BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 45.BRAZIL BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 46.SAUDI ARABIA BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 47.SOUTH AFRICA BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 48.REST OF LAMEA BIOTECH INGREDIENTS MARKET REVENUE, 2020–2028 (MILLION)
FIGURE 49.MARKET PLAYER POSITIONING, 2020
FIGURE 50.TOP WINNING STRATEGIES, BY YEAR, 2017–2021
FIGURE 51.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2021 (%)
FIGURE 52.TOP WINNING STRATEGIES, BY COMPANY, 2017–2021
FIGURE 53.ASTRAZENECA: NET SALES, 2017–2019 ($MILLION)
FIGURE 54.ASTRAZENECA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 55.ASTRAZENECA: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 56.MERCK & CO.: NET SALES, 2017–2019 ($MILLION)
FIGURE 57.MERCK & CO.: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 58.MERCK & CO.: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 59.ABBVIE: NET SALES, 2017–2019 ($MILLION)
FIGURE 60.ABBVIE: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 61.ABBVIE: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 62.MYLAN: NET SALES, 2017–2019 ($MILLION)
FIGURE 63.MYLAN: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 64.MYLAN: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 65.MYLAN: REVENUE SHARE BY COUNTRY OF SUBSIDIARIES, 2019 (%)
FIGURE 66.KOBE: NET SALES, 2017–2019 ($MILLION)
FIGURE 67.NOVARTIS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 68.NOVARTIS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 69.NOVARTIS: REVENUE SHARE BY DIVISION, 2019 (%)
FIGURE 70.PFIZER INC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 71.PFIZER INC.: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 72.PFIZER INC.: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 73.SANOFI: NET SALES, 2017–2019 ($MILLION)
FIGURE 74.SANOFI: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 75.SANOFI: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 76.TEVA: NET SALES, 2017–2019 ($MILLION)
FIGURE 77.TEVA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 78.ELI LILLY AND COMPANY: NET SALES, 2017–2019 ($MILLION)
FIGURE 79.ELI LILLY AND COMPANY: REVENUE SHARE BY REGION, 2019 (%)

 
 

According to the insights from CXOs, the biotech ingredients market is highly fragmented in nature. Biotech ingredients are substances made from biologically copying DNA or engineering similar compounds that offer several benefits. This is also marked with significant shift experienced in consumers opting for biotech ingredient-based products instead of synthetic ingredients harmful for human as well as environment. The market is still at a stage where research and development activities are still large part of the industry’s growth. Market players are continuously engaged in launching new products with increased application of biotech ingredients. Moreover, demand from food & beverages, personal care, and health supplements industries act as growth drivers for the industry. In addition, production process for the same is costly and have high complexities. This leads to low availability of raw materials, which restrains the biotech ingredients market growth. However, technological advancements aimed at reducing cost and increasing product output are expected to offer significant growth opportunities for the industry growth in the coming years. 

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The notable shift in demand from synthetic ingredients to biotech or organic ingredients attributed to the rising awareness in consumers regarding the harmful effects of synthetic products are the key factors driving the Biotech Ingredients market.

A. The market share of Biotech Ingredients market $51.3 billion in 2020.

A. The rising use of generic medicines has also led to rise in demand for organic or herbal generics and growing use of biotech ingredients in food & beverage industry.

A. Europe and Asia-Pacific will provide more business opportunities for Biotech Ingredients market in future.

A. Product launch and acquisition are the key growth strategies of Biotech Ingredients market players.

A. The leading players in the market are Pfizer Inc., Novartis International AG, Merck & Co., Teva Pharmaceutical Industries Ltd., Mylan, Inc., Boehringer Ingelheim, Sanofi, AbbVie, Eli Lilly and Company, and AstraZeneca plc.

A. Active Pharmaceutical Ingredients segment based on type of ingredients holds the maximum market share of the Biotech Ingredients market.

A. Food & beverage, medicine, personal care, and cosmetics are the potential customers of Biotech Ingredients industry.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Biotech Ingredients Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers